Delaware Valley Urology Merges with New Jersey Urology

1 Apr 2018 News

The merger creates largest urology network in the United States

We’re pleased to announce that effective April 1, 2018, Delaware Valley Urology, LLC, has merged with New Jersey Urology, LLC.

The newly-formed organization will create the largest group of urologists in the United States, with 96 providers in 46 locations across the state of New Jersey, including 4 Cancer Treatment Centers.

The combined organization has identified both clinical and operational improvements as a result of the merger, which will lead to more robust resources for patients and employees alike.

“Our organizations have similar missions — to provide the best, compassionate urological care to the wonderful communities we serve,” said Kathy Schleider, Chief Operating Officer at Delaware Valley Urology. “We believe that together, we’ll be in a stronger position to provide high-quality, innovative care and serve a greater population.”

The central business office for the newly-formed organization will be located in Bloomfield, NJ, with regional operations in Mount Laurel, NJ.

“Although our name will change, we will remain committed to clinical excellence, compassionate patient service, and exceptional care delivery,” said Dr. David Sussman, President at Delaware Valley Urology. “Our commitment to our patients will always be our top priority.”

Dr. Mark Fallick Appointed Medical Director of Surgical Services at Virtua

19 Feb 2018 News

Delaware Valley Urology’s Mark L. Fallick, MD, MBA, FACS, has been appointed Medical Director of Surgery at Virtua Hospitals. Under the leadership of Howard J. Winter, MD, Program Director of Surgery at Virtua Hospitals, Dr. Fallick will offer administrative support of the surgical program, including the development and organization of department protocols.

A graduate of The Heller School for Social Policy and Management at Brandeis University in Waltham, MA, Dr. Fallick was amongst the first graduating class from Heller’s Executive MBA (EMBA) for Physicians. This program – designed for practicing physicians – focuses on the development of physician leaders in healthcare organizations, covering topics ranging from health policy and economics to operational systems management.

Board certified by the American Board of Urology, Dr. Fallick is fellowship-trained and has extensive experience in men’s health, male infertility, treatment of low-testosterone, and microsurgery, including vasectomy reversal. He has been performing no-scalpel vasectomies and minimally-invasive procedures to treat enlarged prostate for 20 years.

Dr. Fallick maintains privileges at Virtua Hospitals in Marlton and Voorhees, NJ.

 

About Delaware Valley Urology, LLC: Delaware Valley Urology, LLC, is the largest network of urology specialists in Southern New Jersey. Our team of more than 30 physicians offer top-notch urological care in 11 office locations spanning six counties from central Jersey to the Jersey shore, in addition to maintaining privileges at more than a dozen area hospitals. Our team provides diagnosis and treatment for a wide range of urological conditions, from general urology to advanced prostate cancer. With personalized nurse navigation and a centralized patient access center, patient care is our top priority. Learn more at www.dvurology.com.

About Virtua: As one of New Jersey’s largest, non-profit health systems, Virtua provides comprehensive health care services to achieve its mission to help people be well, get well and stay well. Virtua provides services through Virtua Medical Group with 500 physicians and other clinicians, and at its urgent care centers, hospitals, ambulatory surgery centers, health and wellness centers, fitness centers, home health services, long-term care and rehabilitation centers, and paramedic program. A leader in maternal and child health services, Virtua delivers nearly 8,000 babies a year. It provides health services to 1,500 businesses, and participates in Virtua Physician Partners, a clinically integrated network of 1,000 physicians and other clinicians. Virtua is affiliated with Penn Medicine for cancer and neuroscience and the Children’s Hospital of Philadelphia (CHOP) for pediatrics. It employs over 9,000 and has been honored as the #1 Best Place to Work in the Delaware Valley many times since 2007. It is the recipient of a 4-star rating from the Centers for Medicare and Medicaid Services (CMS) for quality of care, and its hospitals earned straight A’s in patient safety by The Leapfrog Group and the 2016 Patient Safety Award from Healthgrades. U.S. News and World Report ranked Virtua’s Mount Holly and Voorhees hospitals as High Performing Hospitals and Voorhees as a Best Regional Hospital. Virtua is also the recipient of the Consumer Choice Award from the National Research Corporation.

Delaware Valley Urology, LLC partners with AtlantiCare Physician Group

5 Feb 2018 News

Delaware Valley Urology, LLC (DVU) has partnered with AtlantiCare Physician Group Specialty Care, a member of Geisinger.

DVU services at AtlantiCare include diagnosis and treatment for a wide range of general and specialty urological care for adults.

A team of DVU physicians sees patients at the AtlantiCare Health Park Egg Harbor Township Campus, Building 800, 2500 English Creek Avenue, Egg Harbor Township, NJ. The physicians, all members of AtlantiCare’s Medical Staff, also have privileges at AtlantiCare Regional Medical Center. They include:

  • Randy Ackerman, MD
  • Scott Asroff, MD
  • Robert Barsky, DO
  • Jeffrey Becker, MD
  • Douglas Berkman, MD
  • Michael Bernstein, MD
  • Gordon Brown, DO
  • Rajen Butani, MD
  • Shih-Han Chow, MD
  • Philip Dorsey Jr., MD
  • Mark Fallick, MD
  • Samuel Goldenberg, MD
  • Robert Goldlust, MD
  • Sanjay Kasturi, MD
  • Louis Keeler III, MD
  • Mitchell Kotler, MD
  • Evan Krisch, MD
  • Robert Linden, MD
  • Thomas Mueller, MD
  • Marcella Nachmann, DO
  • Adam Perzin, MD
  • James Sipio, MD
  • David Sussman, DO
  • Paul Thur, MD
  • Heather Wargo, MD

AtlantiCare Physician Group offers primary, specialty and urgent care services in locations throughout five counties in southern New Jersey.

To schedule an appointment with a Delaware Valley Urology provider or other AtlantiCare provider, or for more information about AtlantiCare, visit www.atlanticare.org, call the AtlantiCare Access Center at 1-888-569-1000, or find AtlantiCare on Facebook.

AtlantiCare, a member of Geisinger, is an integrated system of services designed to help people achieve optimal health. It includes AtlantiCare Regional Medical Center, AtlantiCare Health Engagement, the AtlantiCare Foundation, and AtlantiCare Health Services. Its more than 5,900 employees and more than 900 physicians serve the community in nearly 90 locations. A 2009 Malcolm Baldrige Award winner, AtlantiCare was also included in Modern Healthcare’s Best Places to Work in Healthcare in 2010. ARMC became the 105th hospital in the nation to attain status as a Magnet™ designated hospital in March of 2004 and was redesignated a Magnet™ hospital in 2008 and 2013. Learn more at www.atlanticare.org.

Delaware Valley Urology, LLC, is the largest network of urology specialists in southern New Jersey. Its team of more than 30 physicians offers advanced urological care in 11 office locations spanning six counties from southern to central New Jersey. DVU providers have privileges at more than a dozen hospitals, including AtlantiCare Regional Medical Center. The DVU team provides diagnosis and treatment for a wide range of urological conditions, from general urology to advanced prostate cancer. It offers personalized nurse navigation and a centralized patient access center. Learn more at www.dvurology.com.

Dr. David Sussman and Dr. Thomas Mueller Designated as Urolift® Centers of Excellence

28 Dec 2017 News

We’re proud to announce that the offices of Dr. David O. Sussman and Dr. Thomas J. Mueller have been designated as UroLift® Centers of Excellence. The designation recognizes that Drs. Sussman and Mueller have achieved a high level of training and experience, leading to “best-in-class” clinical results with the UroLift System. Delaware Valley Urology continuously demonstrates a commitment to excellent care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH) or enlarged prostate.

“The UroLift System is a breakthrough minimally invasive treatment that typically takes less than an hour and can offer multiple benefits for men with enlarged prostate – no cutting, heating, or removal of tissue, minimal downtime, no compromise of sexual function, and no need for continued medications,” said Dr. Mueller. “I am proud that we are a national leader offering this breakthrough treatment option.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called “BPH6” demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering more rapid recovery.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System

NeoTract’s FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

DVU Physicians Honored as 2017 South Jersey Top Docs

7 Dec 2017 News

As 2017 comes to a close, we’re proud to reflect on the physicians at Delaware Valley Urology who have been chosen by their patients and their peers as 2017 “Top Docs.”

South Jersey Magazine 2017 Top Physicians:

  • Dr. Robert Barsky – Top Urologist, nominated by Kennedy Health
  • Dr. Thomas Mueller – Top Urologist, Readers’ Choice

Read South Jersey Magazine’s complete list here >

SJ Mag 2017 Top Docs:

  • Dr. Adam Perzin – Top Urologist, selected by SJ Mag Patient Poll
  • Dr. Evan Krisch – Top Urologist, selected by SJ Physicians
  • Dr. David Sussman – Top Urologist, selected by SJ Physicians

Read SJ Mag’s complete list here >

NJU Welcomes Dr. Nyarai Mushonga

4 Dec 2017 News

Nyarai Mushonga, MD is board certified by the American Board of Obstetrics and Gynecology and board eligible in female pelvic medicine and reconstructive surgery specializing in:

  • Bladder dysfunction disorders
  • Bladder pain
  • Cystocele
  • Fecal incontinence
  • Female pelvic pain
  • Fistulas
  • Hysterectomy
  • Labial hypertrophy
  • Overactive bladder (OAB)
  • Pelvic floor dysfunction
  • Pelvic organ prolapses
  • Recurrent urinary tract infections (UTIs)
  • Robotic surgery
  • Urethral diverticulum
  • Urine leakage
  • Vaginal rejuvenation

Education

  • Rutgers University—undergraduate degree
  • Robert Wood Johnson Medical School—medical degree
  • Johns Hopkins Bloomberg School of Public Health—master’s degree in public health
  • Greenwich Hospital—internal medicine residency internship
  • Cooper University Hospital— residency in obstetrics and gynecology
  • Mount Sinai School of Medicine—fellowship in female pelvic medicine and reconstructive surgery

Hospital Affiliations

  • HackensackUMC Mountainside

Locations

  • Glen Ridge

3 Common Myths About Prostate Cancer Treatments, Debunked

14 Sep 2017 Blog

The internet is a never-ending double-edged sword. On the one hand, a world of indefinite knowledge is simply a click or touch away. On the other, misinformation is sometimes hidden under the guise of truth. This seems to be the case for a variety of topics, including prostate cancer.

Thankfully, we’re here to shed some light on some untruths regarding prostate cancer that the web has spun for far too long.

Myth #1: Ginger can treat and prevent prostate cancer.

Fact: Before we start badmouthing ginger, what we can say about this biting root is that it does have some wonderful stomach-soothing properties. Plus, it tastes great in tea. That said, it does absolutely nothing when it comes to treating or preventing prostate cancer.

Unfortunately, certain websites that cater to “natural” remedies for everything from hangnails to cancer will cling to small studies—such as this one—that merely hint or suggest a small kernel of truth to an otherwise unsubstantiated lie.

Myth #2: Golden berries aid in destroying prostate cancer cells.

Fact: This is also quite false. Think about it: If these berries had even the slightest hope of curing cancer, don’t you think science would be on this like white on rice?

Well, it isn’t. A simple Google search will show that there are no studies currently being conducted nor are there studies even suggesting that golden berries will effectively treat anything, let alone cure cancer.

What you will find, however, is a long list of “natural” websites regurgitating the same anecdotal evidence regarding this “magical” fruit. That, regrettably, is not proof.

Myth #3: Frequent ejaculation may reduce the risk of prostate cancer.

Fact: Of all the things you could do in your spare time to reduce your risk of developing prostate cancer, this one … Well, it basically lives at the bottom of the list.

There are studies that suggest a decreased risk of prostate cancer, but the number of ejaculations to decrease the risk has never been quantified. Also, researchers can’t figure out what one has to do with the other in the first place. That lack of understanding doesn’t bode well as a confidence booster, especially when it comes to health.

In short, we don’t recommend putting all of your eggs into this particular basket, no matter how enticing the idea may seem.

These medical rumors are truly dangerous as they promote themselves as alternates to lifesaving, science-based treatments, like robotic-assisted laparoscopic prostatectomy and radiation therapy. By debunking these harmful myths, we hope to encourage men like you to be proactive with your health. We further implore you to trust science to help you detect prostate cancer early with yearly exams, prostate-specific antigen (PSA) blood tests and doctor follow-ups.

For more information about prostate cancer or to schedule an appointment with one of our urology specialists, contact us at one of our convenient locations today.

Do Male Fertility Supplements Work?

16 Aug 2017 Blog

If you’re a male that struggles with infertility, you might have been tempted to try one of the many male fertility supplements that are available on the market. But do they really help increase sperm count and mobility, or are they completely ineffective?

A lot of research has been done to study the effectiveness of fertility supplements, but evidence is still limited because of the variations in dosage and questions about the cause of infertility in patients.

Supplements for Male Infertility

Though the effectiveness of supplements is questionable, there are a few supplements that have shown promise for increasing sperm count and mobility:

  • Zinc and Folate Supplements Folate is known as a vitamin that’s used for healthy pregnancies, but it can also increase sperm count and motility when used in combination with zinc supplements.
  • Vitamins A, C, and E These antioxidant vitamins might help increase fertility because they can potentially reduce oxidative stress. Stress is known to reduce sperm count.
  • Coenzyme Q-10 Similar to vitamins A, C, and E, coenzyme Q-10 has been known to protect cells from oxidative stress, which can be beneficial for damaged sperm.
  • Carnitine Carnitine is an amino acid that helps your body turn fat to energy. According to recent studies, it can also help sperm cells generate the energy they need to function optimally.
  • Selenium Selenium has been shown to increase sperm count and motility when taken with other vitamins, especially if a man has low selenium levels.

Treating Male Infertility in New Jersey

Sperm cells are sensitive, and they require good nutrition and antioxidants to perform properly. In order to come up with the best treatment for male infertility, it’s important to consult a physician before trying any supplements. In order to get to the root of the problem, a urologist will typically perform at least one of the following tests:

  • Sperm and semen analysis
  • Physical exam
  • Hormone evaluation
  • Testicular biopsy

If you’re struggling with male infertility and are ready to get answers, contact an NJU office near you. Our urologists will give you the care you need to effectively treat infertility.

Men’s Health Month: Cancer in Men

16 Jun 2017 Blog

June is men’s health month and we want to take the time to educate you on important facts regarding your health or the health of the men in your life.

Top Cancers in Men

Out of the top 6 most common cancers in men, 3 of them are urology related:

Prostate Cancer

Prostate cancer is #1 on the list of most common cancers in men. According to the most accurate recent figures in 2014, 233,000 men will be diagnosed with prostate cancer, which is about 27% of all cancer diagnoses. About 1 in 6 men will be diagnosed with prostate cancer in their lifetime. The average age for this diagnosis is between the ages of 65-69 and that accounts for 65% of all diagnoses.

The prostate is a gland that assists with reproduction, but as you age, it increases in size and can lead to complications such as BPH and prostate cancer.

What can you do?

There are two tests you can get, the PSA and DRE tests. Getting screened isn’t necessarily a guarantee you can get diagnosed and treated, but it can help if your urologist thinks you make be at risk for prostate cancer. Talk to your urologist if you think you should be screened.

Bladder Cancer

Bladder cancer is #4 on the list of the most common cancers in men. It’s estimated that about 56,000 men will be diagnosed with bladder cancer. Unlike prostate cancer, which tends to be more genetically caused, bladder cancer is preventable. However, if not treated early, bladder cancer can spread to lymph nodes of the pelvis, abdomen or even the neck.

What can you do?

A mentioned, while the risk of bladder cancer can increase from family history and other genetic factors, age and smoking are the two biggest risk factors. Most men diagnosed are over the age of 70, but smoking can increase your risk at any age. Quitting smoking can help significantly reduce your chances of getting bladder cancer (and lung cancer, which is #2 on the most common cancers in men list)

Kidney Cancer

Lastly, kidney cancer, also known as renal cancer, is #6 on the list. About 39,000 cases of kidney cancer are expected to be diagnosed in men. Most cases of kidney cancer first appear in the lining of small tubes in the kidney called tubules. Luckily, most of the time this is found before it spreads. Most men diagnosed are 60 or older.

What can you do?

Two big risk factors for kidney cancer are smoking and obesity. If you quit smoking and try to live a healthier lifestyle (being more active, eating more rich fruits and vegetables and less fatty meats) can greatly reduce your chances of getting kidney cancer

In light of men’s health month, schedule an appointment with your urologist for a check up!

1 2 3

Search

+